Mittwoch 01.03.2023 | 17:00 – 20:00 UhrSehr geehrte Kolleginnen Kollegen,hiermit möchten wir sie herzlich zum 18. Symposium Genetik und Schwangerschaft einladen. In diesem Jahr greifen wir noch einm..
Following the investment in acquiring NIPD Genetics, Medicover has been recently awarded Invest Cyprus International Investment Awards, a prize honoring international investors, individuals and compa..
Did you know that VERACITY accurately detects the most common chromosomal changes? It requires only a simple blood draw from a pregnant woman and is safe for the baby. Amazing, right? We got more ..
Medicover Genetics recently marked its attendance at the 55th edition of the largest genetics conference in Europe, European Human Genetics Conference, held in Vienna, from 11 to 14 June 2022. A team..
A new quality standard for corona test centers has been achieved by Test & Fly Center and the Munich Airport Laboratory, both being accredited by the Deutsche Akkreditierungsstelle GmbH (DAkkS). ..
The acquisition of NIPD Genetics, a leading innovative biotechnology company based in Cyprus, active in the field of designing, developing, producing, and providing genetic testing solutions, is comp..
October 2021 – Weimar (Germany) – Medicover Genetics held its first annual interdisciplinary genetics meeting (GEM) where scientists, medical geneticists, laboratory technicians and colleagues fr..
Our editors are a diverse group of scientists and physicians specialized in different areas of genetics and genetic testing technologies. Owing to our various backgrounds, our editors represent a broad range of expertise and are responsible for the content shared on our website. Only evidence-based, peer-reviewed, and up-to-date content is shared, and all text is continuously edited to maximize its correctness.
We work closely with laboratories to meet their unique needs and goals. We understand that every laboratory is different, and we tailor our approach to accommodate the specific requirements of each partner. In collaboration with our partners, we design a seamless integrated process, from initial setup to ongoing support and maintenance. Our experienced team provides technical, commercial, and marketing assistance to ensure a successful partnership and optimal performance. We aim to build long-lasting partnerships that are mutually beneficial.
Medicover Genetics’ versatile technology platform can be integrated in a single workflow, offering a multidisciplinary portfolio of genetic tests. All our kits are CE-marked and include user friendly color identification formatting. VERACITY and VERACITY HC kits contain 96 reactions and TarCET IVD kits contain 16 reactions.
Medicover Genetics’ technology transfer platform offers comprehensive testing in a single sequencing run, making it a unique and efficient solution for laboratories of any size. With our technology transfer platform, laboratories can perform multi-disciplinary genetic tests such as NIPT, cardiac, hereditary cancer, carrier screening, and metabolic testing all in a single sequencing run. This improves turnaround time and reduces operational costs while ensuring high-quality results with no compromise on accuracy. Our comprehensive testing approach is ideal for laboratories looking to provide a wide range of genetic tests to their healthcare, associates and patients.
Our technology transfer platform workflow is designed to minimize the risk of errors, reduce hands-on processing and increase the accuracy of test results, providing confidence to patients and physicians in making informed decisions with our user-friendly protocols. The implementation of these protocols ensures that laboratory personnel are trained to follow standardized procedures, reducing the likelihood of human error, and increasing the quality of results.
